124I-zelavespib

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name124I-zelavespib
Drug Alias Namezelavespib-[124I]zelavespib-124-PUH-71Hsp-90-targeted PET imaging agent (Memorial Sloan-Kettering Cancer Center)
ClassificationRadiation-emitting products
Mechanisms of ActionHeat shock protein HSP90 modulators
TargetsHeat shock protein HSP90
Therapy Area/IndicationsAlzheimer DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesSamus Therapeutics IncMemorial Sloan Kettering Cancer Center
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A